ETF Holdings Breakdown of AVIR

Stock NameAtea Pharmaceuticals Inc
TickerAVIR(USD) NASDAQ
TYPECommon Stock
CountryUSA
ISINUS04683R1068

News associated with AVIR

Barclays PLC Raises Stock Holdings in Atea Pharmaceuticals, Inc. (NASDAQ:AVIR)
Barclays PLC lifted its holdings in Atea Pharmaceuticals, Inc. (NASDAQ:AVIR – Free Report) by 13.0% in the fourth quarter, HoldingsChannel reports. The firm owned 200,113 shares of the company’s stock after purchasing an additional 23,036 shares during the quarter. Barclays PLC’s holdings in Atea Pharmaceuticals were worth $671,000 at the end of the most recent […] - 2025-05-08 07:36:45
Marshall Wace LLP Buys New Shares in Atea Pharmaceuticals, Inc. (NASDAQ:AVIR)
Marshall Wace LLP purchased a new position in shares of Atea Pharmaceuticals, Inc. (NASDAQ:AVIR – Free Report) during the 4th quarter, HoldingsChannel reports. The firm purchased 77,581 shares of the company’s stock, valued at approximately $260,000. A number of other hedge funds also recently bought and sold shares of the stock. Barclays PLC increased its […] - 2025-05-05 08:05:05
Atea Pharmaceuticals, Inc. (NASDAQ:AVIR) Stock Position Raised by Federated Hermes Inc.
Federated Hermes Inc. boosted its position in shares of Atea Pharmaceuticals, Inc. (NASDAQ:AVIR – Free Report) by 1.9% during the 4th quarter, HoldingsChannel reports. The firm owned 582,939 shares of the company’s stock after buying an additional 10,856 shares during the quarter. Federated Hermes Inc.’s holdings in Atea Pharmaceuticals were worth $1,953,000 at the end […] - 2025-04-14 08:15:06

AVIR institutional holdings

The following institutional investment holdings of AVIR have been identified

Date ETF ISIN/Name Num Shares Book value
2025-05-08 IE00BYXG2H39 (iShares Nasdaq US Biotechnology UCITS ETF USD (Acc)) 39,167USD 108,101 1.8%
2025-05-08 IE00BDZVHG35 (iShares Nasdaq US Biotechnology UCITS ETF USD (Dist)) 39,167USD 108,101 1.8%
Total =78,334 USD 216,202
Book value of shares is calculated on the adjusted close price of each day (row).

Back to Listing

Disclaimer

All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability for the reliability or accuracy of the data provided. We are not making recommendations for any financial instruments listed on this website.